Browse by category

New drug candidate targeting mitochondria reverses obesity in mice

Researchers at Karolinska Institutet may have found a new way to treat obesity and related disorders by targeting the cells'...

Researchers identify Brown adipose tissue’s 'off-switch'

Professor Jan-Wilhelm Kornfeld from the University of Southern Denmark/the Novo Nordisk Center for Adipocyte Signaling (Adiposign) and...

Tirzepatide reduced sleep apnoea severity by up to nearly two-thirds in adults living with OSA and obesity

Eli Lilly and Company has announced positive topline results from the SURMOUNT-OSA phase 3 clinical trials that showed tirzepatide...

Ultra-processed foods increase the risk of all-cause mortality and to 32 damaging health outcomes

Highly suggestive (class II) evidence indicates that higher exposure to ultra-processed foods is associated with an increased risk of 32...

Disrupted cellular function of “cleaning cells” may explain why some people with obesity develop T2DM

Disrupted function of “cleaning cells” in the body may help to explain why some people with obesity develop type 2 diabetes, while others...

The role of growth hormone secretagogue receptor in obesity-related chronic inflammation

A team comprised primarily of Texas A&M AgriLife Research scientists has made an important discovery that could lead to a novel treatment...

Individuals with obesity are more likely to have benign blood condition MGUS

Individuals with obesity are more likely to have monoclonal gammopathy of undetermined significance (MGUS), a benign blood condition that...

Increased concentration of leptin key to antipsychotic-drug–induced obesity

An increased concentration of the hormone leptin in fat cells is believed to be responsible for weight gain associated with antipsychotic...

Skye to develop nimacimab for the treatment of obesity by targeting the endocannabinoid system

Skye Bioscience, a pharmaceutical company developing drugs targeting the endocannabinoid system (ECS), has announced that it plans to...

Clearmind Medicine’s obesity drug shows positive results in a pre-clinical trial

Clearmind Medicine, a biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major...

Ratioing the resected gastric volume to the number of fired staplers predicts weight loss

Dec 30, 2024

Arrowhead initiates phase 1/2a study of ARO-INHBE for obesity

Dec 29, 2024

Survey finds 93.4% of bariatric patients vs 51.4% of GLP-1 patients have the same treatment again

Dec 26, 2024

Weekly Digest